IL97324A0 - Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus - Google Patents

Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus

Info

Publication number
IL97324A0
IL97324A0 IL97324A IL9732491A IL97324A0 IL 97324 A0 IL97324 A0 IL 97324A0 IL 97324 A IL97324 A IL 97324A IL 9732491 A IL9732491 A IL 9732491A IL 97324 A0 IL97324 A0 IL 97324A0
Authority
IL
Israel
Prior art keywords
arthropoda
infection
expression
growth factor
nerve growth
Prior art date
Application number
IL97324A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of IL97324A0 publication Critical patent/IL97324A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97324A 1990-02-27 1991-02-21 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus IL97324A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT41538A IT1239271B (it) 1990-02-27 1990-02-27 Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante

Publications (1)

Publication Number Publication Date
IL97324A0 true IL97324A0 (en) 1992-05-25

Family

ID=11250839

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97324A IL97324A0 (en) 1990-02-27 1991-02-21 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus

Country Status (6)

Country Link
EP (1) EP0444638A3 (de)
JP (1) JPH05103666A (de)
KR (1) KR910021478A (de)
HU (1) HUT56881A (de)
IL (1) IL97324A0 (de)
IT (1) IT1239271B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573904B1 (de) * 1992-06-08 2001-09-26 Takeda Chemical Industries, Ltd. Therapeutisches Agens für Neutropenie
AU5001793A (en) * 1992-08-12 1994-03-15 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
IT1394690B1 (it) 2008-10-23 2012-07-13 Carli De Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
EP0444638A2 (de) 1991-09-04
IT1239271B (it) 1993-10-01
EP0444638A3 (en) 1992-01-08
IT9041538A0 (it) 1990-02-27
JPH05103666A (ja) 1993-04-27
HU910643D0 (en) 1991-09-30
IT9041538A1 (it) 1991-08-27
HUT56881A (en) 1991-10-28
KR910021478A (ko) 1991-12-20

Similar Documents

Publication Publication Date Title
AU4197389A (en) In vivo infection of live insects with a recombinant baculovirus
FI874819A7 (fi) Ihmisen yhdistelmä-endoteelisolun kasvutekijä.
AU4133789A (en) Biological implant with textured surface
AU1011292A (en) Composite orthopedic implants with asymmetric ply reinforcement
AU3980185A (en) Implant with surface allowing tissue ingrowth
EP0441639A3 (en) Instrument for the application of controlled mechanical loads to tissues in sterile culture
AU583175B2 (en) Biological implant with textured surface
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
AU2898989A (en) Human platelet-derived growth factor receptor
ATE158184T1 (de) Herstellung und verwendung von transfer-faktor
IT1238348B (it) Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
AU581574B2 (en) Fabric treatment to improve dyeability thereof
EP0444638A3 (en) Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
PT86153A (de) Optisch aktive gyrasehemmer ihre herstellung und verwendung als antibiotika
AU7291891A (en) Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
AU6560786A (en) Fishing chair
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
AU4508189A (en) Improvements in or relating to ring spinning
EP0426458A3 (en) Human monocyte growth factor
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
GB8609161D0 (en) Human fibroblast growth factor
NO874552D0 (no) Rekombinant human endotelial cellevekstfaktor.
GB9020138D0 (en) Improvements in and relating to scanning electron microscopes
GB9020140D0 (en) Improvements in and relating to scanning electron microscopes
IT8807090V0 (it) Lettino prendisole con braccioli amovibili per ridurne l'ingombro.